Trial Profile
A study evaluating drug drug interaction between Cetuximab and proton pump inhibitors.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2017
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Carcinoma; Colorectal cancer; Head and neck cancer
- Focus Adverse reactions
- 10 Oct 2017 New trial record
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress